These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1694090)
21. Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells. Yi Q; Dabadghao S; Osterborg A; Bergenbrant S; Holm G Blood; 1997 Sep; 90(5):1960-7. PubMed ID: 9292530 [TBL] [Abstract][Full Text] [Related]
22. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Pellat-Deceunynck C; Bataille R; Robillard N; Harousseau JL; Rapp MJ; Juge-Morineau N; Wijdenes J; Amiot M Blood; 1994 Oct; 84(8):2597-603. PubMed ID: 7522634 [TBL] [Abstract][Full Text] [Related]
23. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease]. Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405 [TBL] [Abstract][Full Text] [Related]
24. Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+). Castle S; Wilkins S; Heck E; Tanzy K; Fahey J Clin Exp Immunol; 1995 Sep; 101(3):487-93. PubMed ID: 7545096 [TBL] [Abstract][Full Text] [Related]
25. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Drach J; Gattringer C; Huber H Clin Exp Immunol; 1991 Mar; 83(3):418-22. PubMed ID: 1706237 [TBL] [Abstract][Full Text] [Related]
26. Natural killer cell activity in monoclonal gammopathies: relation to disease activity. Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786 [TBL] [Abstract][Full Text] [Related]
27. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma. Matsuo Y; Drexler HG; Nishizaki C; Harashima A; Fukuda S; Kozuka T; Sezaki T; Orita K Br J Haematol; 2000 Apr; 109(1):54-63. PubMed ID: 10848782 [TBL] [Abstract][Full Text] [Related]
28. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. Schneider U; van Lessen A; Huhn D; Serke S Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942 [TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine markers expressed by human natural killer (NK) cells are also detectable on human small cell carcinomas, neuroblastomas, and sea urchin coelomocytes. Koros AM Int J Neurosci; 1990 Apr; 51(3-4):255-6. PubMed ID: 1703997 [No Abstract] [Full Text] [Related]
30. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543 [TBL] [Abstract][Full Text] [Related]
31. Lymphoid tissue in the endometrium of women with unexplained infertility: morphometric and immunohistochemical aspects. Klentzeris LD; Bulmer JN; Warren MA; Morrison L; Li TC; Cooke ID Hum Reprod; 1994 Apr; 9(4):646-52. PubMed ID: 7519197 [TBL] [Abstract][Full Text] [Related]
32. Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS. Billadeau D; Greipp P; Ahmann G; Witzig T; Van Ness B Curr Top Microbiol Immunol; 1995; 194():9-16. PubMed ID: 7895525 [No Abstract] [Full Text] [Related]
33. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. Funaro A; Spagnoli GC; Ausiello CM; Alessio M; Roggero S; Delia D; Zaccolo M; Malavasi F J Immunol; 1990 Oct; 145(8):2390-6. PubMed ID: 1976692 [TBL] [Abstract][Full Text] [Related]
34. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action. Adams HC; Stevenaert F; Krejcik J; Van der Borght K; Smets T; Bald J; Abraham Y; Ceulemans H; Chiu C; Vanhoof G; Usmani SZ; Plesner T; Lonial S; Nijhof I; Lokhorst HM; Mutis T; van de Donk NWCJ; Sasser AK; Casneuf T Cytometry A; 2019 Mar; 95(3):279-289. PubMed ID: 30536810 [TBL] [Abstract][Full Text] [Related]
35. High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma. Kawano MM; Mahmoud MS; Huang N; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A Br J Haematol; 1995 Dec; 91(4):860-4. PubMed ID: 8547130 [TBL] [Abstract][Full Text] [Related]
36. A new staging system for multiple myeloma based on the number of S-phase plasma cells. San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998 [TBL] [Abstract][Full Text] [Related]
37. [Detection of myeloma cells in the peripheral blood using flow cytometry]. Adam Z; Klabusay M; Vorlícek J; Hájek R Vnitr Lek; 1997 Sep; 43(9):592-8. PubMed ID: 9750468 [TBL] [Abstract][Full Text] [Related]
38. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711 [TBL] [Abstract][Full Text] [Related]
39. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis. Matsuda M; Gono T; Shimojima Y; Hoshii Y; Ikeda S Amyloid; 2003 Jun; 10(2):110-6. PubMed ID: 12964418 [TBL] [Abstract][Full Text] [Related]
40. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state. Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]